155 related articles for article (PubMed ID: 31174330)
1. Epidemiology of Breed-Related Mast Cell Tumour Occurrence and Prognostic Significance of Clinical Features in a Defined Population of Dogs in West-Central Italy.
Pierini A; Lubas G; Gori E; Binanti D; Millanta F; Marchetti V
Vet Sci; 2019 Jun; 6(2):. PubMed ID: 31174330
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and Distribution of Canine Cutaneous Mast Cell Tumour Characteristics Among Predisposed Breeds.
Śmiech A; Łopuszyński W; Ślaska B; Bulak K; Jasik A
J Vet Res; 2019 Mar; 63(1):141-148. PubMed ID: 30989146
[TBL] [Abstract][Full Text] [Related]
3. Analysis of risk factors for canine mast cell tumors based on the Kiupel and Patnaik grading system among dogs with skin tumors.
Martins AL; Carvalho FF; Mesquita JR; Gärtner F; Amorim I
Open Vet J; 2021; 11(4):619-634. PubMed ID: 35070857
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological Study of Canine Mast Cell Tumours According to the Histological Malignancy Grade.
Śmiech A; Ślaska B; Łopuszyński W; Jasik A; Szczepanik M; Wilkołek P
Pol J Vet Sci; 2017 Sep; 20(3):455-465. PubMed ID: 29166281
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two-grade malignancy classification.
Śmiech A; Ślaska B; Łopuszyński W; Jasik A; Bochyńska D; Dąbrowski R
Acta Vet Scand; 2018 Nov; 60(1):70. PubMed ID: 30390687
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for mast cell tumours in dogs in England.
Shoop SJ; Marlow S; Church DB; English K; McGreevy PD; Stell AJ; Thomson PC; O'Neill DG; Brodbelt DC
Canine Genet Epidemiol; 2015; 2():1. PubMed ID: 26401329
[TBL] [Abstract][Full Text] [Related]
8. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
10. Identification of two molecular subtypes in canine mast cell tumours through gene expression profiling.
Pulz LH; Barra CN; Alexandre PA; Huete GC; Cadrobbi KG; Nishiya AT; de Freitas SH; Fukumasu H; Strefezzi RF
PLoS One; 2019; 14(6):e0217343. PubMed ID: 31216299
[TBL] [Abstract][Full Text] [Related]
11. Sentinel Lymph Node Mapping with Indirect Lymphangiography for Canine Mast Cell Tumour.
De Bonis A; Collivignarelli F; Paolini A; Falerno I; Rinaldi V; Tamburro R; Bianchi A; Terragni R; Gianfelici J; Frescura P; Dolce G; Pagni E; Bucci R; Vignoli M
Vet Sci; 2022 Sep; 9(9):. PubMed ID: 36136700
[TBL] [Abstract][Full Text] [Related]
12. Association of breed and histopathological grade in canine mast cell tumours.
Mochizuki H; Motsinger-Reif A; Bettini C; Moroff S; Breen M
Vet Comp Oncol; 2017 Sep; 15(3):829-839. PubMed ID: 27198171
[TBL] [Abstract][Full Text] [Related]
13. Patient and tumour factors influencing canine mast cell tumour histological grade and mitotic index.
Reynolds BD; Thomson MJ; O'Connell K; Morgan EJ; Gummow B
Vet Comp Oncol; 2019 Sep; 17(3):338-344. PubMed ID: 30891882
[TBL] [Abstract][Full Text] [Related]
14. Breed related odds ratio and anatomic distribution of canine mast cell tumours in Austria. Retrospective study of cases in the years 2000-2010.
Leidinger EF; Freeman K; Kirtz G; Hooijberg EH; Sick K
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014; 42(6):367-73. PubMed ID: 25418504
[TBL] [Abstract][Full Text] [Related]
15. Extensive staging has no prognostic value in dogs with low-risk mast cell tumours.
Fejös C; Troedson K; Ignatenko N; Zablotski Y; Hirschberger J
Vet Comp Oncol; 2022 Mar; 20(1):265-275. PubMed ID: 34564910
[TBL] [Abstract][Full Text] [Related]
16. Canine oral mucosal mast cell tumours.
Elliott JW; Cripps P; Blackwood L; Berlato D; Murphy S; Grant IA
Vet Comp Oncol; 2016 Mar; 14(1):101-11. PubMed ID: 24215587
[TBL] [Abstract][Full Text] [Related]
17. High-Grade, Stage 2 Mast Cell Tumors: Outcome in Dogs With Local and Systemic Therapy.
Burge R; Woolard KD; Willcox JL; Rebhun RB; Burton JH; Al-Nadaf S; Skorupski KA
J Am Anim Hosp Assoc; 2023 Jul; 59(4):167-176. PubMed ID: 37432790
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures.
Worley DR
Vet Comp Oncol; 2014 Sep; 12(3):215-26. PubMed ID: 22958227
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic impact of regional lymphadenectomy in canine stage II cutaneous mast cell tumours.
Marconato L; Polton G; Stefanello D; Morello E; Ferrari R; Henriques J; Tortorella G; Benali SL; Bergottini R; Vasconi ME; Annoni M; Sabattini S
Vet Comp Oncol; 2018 Dec; 16(4):580-589. PubMed ID: 30047226
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous MCTs: associations with spay/neuter status, breed, body size, and phylogenetic cluster.
White CR; Hohenhaus AE; Kelsey J; Procter-Gray E
J Am Anim Hosp Assoc; 2011; 47(3):210-6. PubMed ID: 21498594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
